Revvity, Inc. (PKN.F)
| Previous close | 98.00 |
| Open | 96.44 |
| Bid | 97.70 x 30000 |
| Ask | 99.68 x 30000 |
| Day's range | 96.44 - 96.44 |
| 52-week range | 76.50 - 118.65 |
| Volume | |
| Avg. volume | 4 |
| Market cap | 11.9B |
| Beta (5Y monthly) | 1.08 |
| PE ratio (TTM) | 70.39 |
| EPS (TTM) | 1.37 |
| Earnings date | 30 July 2024 - 05 Aug 2024 |
| Forward dividend & yield | 0.26 (0.27%) |
| Ex-dividend date | 19 July 2024 |
| 1y target est | 179.17 |
GlobeNewswireBionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
Bionano has entered into a software marketing agreement with Revvity, Inc. (Revvity) under which Revvity will market and commercialize Bionano’s VIA™ software to Revvity’s next generation sequencing (NGS) customers as part of its newborn sequencing research workflowVIA is expected to enhance Revvity’s newborn sequencing solution by adding an assessment of copy number variation (CNV) to the NGS solution report and streamlining the workflow’s interpretation capabilities SAN DIEGO, June 20, 2024 (G
ZacksWhy Is Pediatrix Medical Group (MD) Down 15.9% Since Last Earnings Report?
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksCencora (COR) Down 1.9% Since Last Earnings Report: Can It Rebound?
Cencora (COR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
